BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 113206)

  • 1. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.
    Chiu P; Olsen DM; Borys HK; Karler R; Turkanis SA
    Epilepsia; 1979 Aug; 20(4):365-75. PubMed ID: 113206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats.
    Turkanis SA; Smiley KA; Borys HK; Olsen DM; Karler R
    Epilepsia; 1979 Aug; 20(4):351-63. PubMed ID: 477630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
    Colasanti BK; Lindamood C; Craig CR
    Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats.
    Turkanis SA; Karler R
    Neuropharmacology; 1982 Jan; 21(1):7-13. PubMed ID: 6278353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
    Turkanis SA; Karler R
    Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of delta9-tetrahydrocannabinol and cannabidiol on photically evoked after-discharge potentials.
    Turkanis SA; Chiu P; Borys HK; Karler R
    Psychopharmacology (Berl); 1977 Apr; 52(2):207-12. PubMed ID: 407606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabinoids as potential antiepileptics.
    Karler R; Turkanis SA
    J Clin Pharmacol; 1981; 21(S1):437S-448S. PubMed ID: 6975285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiseizure effects of the cannabinoids in the amygdala-kindling model.
    Fallah MS; Dlugosz L; Scott BW; Thompson MD; Burnham WM
    Epilepsia; 2021 Sep; 62(9):2274-2282. PubMed ID: 34251027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
    Consroe P; Wolkin A
    J Pharmacol Exp Ther; 1977 Apr; 201(1):26-32. PubMed ID: 850145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. delta 9-Tetrahydrocannabinol and cannabidiol: dose-dependent effects on evoked potentials in the hippocampal slice.
    Kujtan PW; Carlen PL; Kapur BM
    Can J Physiol Pharmacol; 1983 Apr; 61(4):420-6. PubMed ID: 6305469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ
    Javadzadeh Y; Santos A; Aquilino MS; Mylvaganam S; Urban K; Carlen PL
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
    Zuardi AW; Teixeira NA; Karniol IC
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic properties of the cannabinoids.
    Turkanis SA; Karler R
    J Clin Pharmacol; 1981; 21(S1):449S-463S. PubMed ID: 6271840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
    Karler R; Turkanis SA
    Br J Pharmacol; 1980 Mar; 68(3):479-84. PubMed ID: 6301593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
    Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
    Turkanis SA; Karler R
    Neuropharmacology; 1986 Nov; 25(11):1273-8. PubMed ID: 3025765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
    Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
    Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
    Mascal M; Hafezi N; Wang D; Hu Y; Serra G; Dallas ML; Spencer JPE
    Sci Rep; 2019 May; 9(1):7778. PubMed ID: 31123271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.